The New York Times
When Juliet Jacobs found out she had lung ,
she was terrified, but realized that her hope lay in getting the best
treatment medicine could offer. So she got a second opinion, then a
third. In February of 2010, she ended up at , where she entered a research study whose promise seemed stunning.
Doctors would assess her
cells, looking for gene patterns that would determine which drugs would
best attack her particular cancer. She would not waste precious time
with ineffective drugs or trial-and-error treatment... Read More